Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Tonti

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Review of Gastroenterology & Hepatology|May 29, 2020
Statin use does not decrease the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitisAntonio Facciorusso, Vincenzo Rosario Buccino, Paolo Tonti, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 12, 2016
Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusionTommaso Martino, Donato Melchionda, Paolo Tonti, et al.
Journal of Clinical Gastroenterology|October 18, 2003
Argon plasma coagulation of hemorrhagic solitary rectal ulcer syndromeVincenzo Stoppino, Rosario Cuomo, Paolo Tonti, et al.
Gastrointestinal Endoscopy|May 21, 2020
Impact of fellow participation on colon adenoma detection rates: a multicenter randomized trialAntonio Facciorusso, Vincenzo Rosario Buccino, Paolo Tonti, et al.
The American Journal of Gastroenterology|December 18, 2008
High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized studyAngelo Andriulli, Silvano Loperfido, Rosaria Focareta, et al.
Expert Opinion on Pharmacotherapy|June 26, 2023
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world studyAntonio Tursi, Giammarco Mocci, Linda Cingolani, et al.
Expert Opinion on Biological Therapy|January 22, 2024
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life studyAntonio Tursi, Giammarco Mocci, Franco Scaldaferri, et al.
Journal of Clinical Medicine|November 13, 2025
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World StudyGiammarco Mocci, Antonio Tursi, Franco Scaldaferri, et al.
Journal of Clinical Medicine|December 17, 2024
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort StudyGiammarco Mocci, Antonio Tursi, Franco Scaldaferri, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Review of Gastroenterology & Hepatology|May 29, 2020
Statin use does not decrease the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitisAntonio Facciorusso, Vincenzo Rosario Buccino, Paolo Tonti, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 12, 2016
Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusionTommaso Martino, Donato Melchionda, Paolo Tonti, et al.
Journal of Clinical Gastroenterology|October 18, 2003
Argon plasma coagulation of hemorrhagic solitary rectal ulcer syndromeVincenzo Stoppino, Rosario Cuomo, Paolo Tonti, et al.
Gastrointestinal Endoscopy|May 21, 2020
Impact of fellow participation on colon adenoma detection rates: a multicenter randomized trialAntonio Facciorusso, Vincenzo Rosario Buccino, Paolo Tonti, et al.
The American Journal of Gastroenterology|December 18, 2008
High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized studyAngelo Andriulli, Silvano Loperfido, Rosaria Focareta, et al.
Expert Opinion on Pharmacotherapy|June 26, 2023
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world studyAntonio Tursi, Giammarco Mocci, Linda Cingolani, et al.
Expert Opinion on Biological Therapy|January 22, 2024
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life studyAntonio Tursi, Giammarco Mocci, Franco Scaldaferri, et al.
Journal of Clinical Medicine|November 13, 2025
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World StudyGiammarco Mocci, Antonio Tursi, Franco Scaldaferri, et al.
Journal of Clinical Medicine|December 17, 2024
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort StudyGiammarco Mocci, Antonio Tursi, Franco Scaldaferri, et al.
Pageof 1